Evidence map›Paper›PMID 20144623›Full record

ReviewMicrovascular research2010

Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.

Jörn Tongers, Jerome G Roncalli, Douglas W Losordo

Abstract readReview
In one paragraph

Review in Microvascular research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Transplantation of CD34+ cells for myocardial ischemia.World journal of transplantation · 2021
    Review
  8. Review
  9. Article
  10. Differential Expression of Vascular Endothelial Growth Factor-AJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. High qualityInternational journal of medical sciences · 2017
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jörn TongersFeinberg Cardiovascular Research Institute, Northwestern University, Tarry 12-703, 303 East Chicago Avenue, Chicago, IL 60611, USA.
Jerome G Roncalli
Douglas W Losordo

Funding

Therapeutic Angiogenesis in Vascular Medicine IVR01HL053354 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 1995 to 2015
$4.2M
RE-ENDOTHELIALIZATION AND RESTENOSIS IIR01HL057516 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1997 to 2008
$3.3M
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PADR01HL077428 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2011
$2.5M
Role of Progenitor Cells in Cardiovascular MedicineR01HL080137 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2010
$1.9M
Novel approaches to ischemic tissue repairR01HL095874 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISHORE, RAJ · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL053354NHLBI NIH HHS R01 HL057516NHLBI NIH HHS R01 HL077428NHLBI NIH HHS R01 HL080137NHLBI NIH HHS R01 HL095874NHLBI NIH HHS R01 HL53354NHLBI NIH HHS R01 HL77428NHLBI NIH HHS R01 HL80137NHLBI NIH HHS R01 HL95874
6 · The paper itself

Abstract

Cell-based therapy has emerged as a promising therapeutic tool for treatment of ischemic cardiovascular disease. Both unselected bone marrow-derived mononuclear cells (BMNCs), which include stem/progenitor cells and several other cell types, and endothelial progenitor cells (EPCs), a subpopulation of BMNCs, display regenerative potential in ischemic tissue. Abundant evidence supports the involvement of EPCs in capillary growth, and EPCs also appear to participate in the formation of collateral vessels. Collectively, these effects have led to improved perfusion and functional recovery in animal models of myocardial and peripheral ischemia, and in early clinical trials, the therapeutic administration of EPCs to patients with myocardial infarction or chronic angina has been associated with positive trends in perfusion. EPCs also contribute to endothelial repair and may, consequently, impede the development or progression of arteriosclerosis. This review provides a brief summary of the preclinical and clinical evidence for the role of EPCs in blood-vessel formation and repair during ischemic cardiovascular disease.

Indexed as

Collateral CirculationEndothelial CellsNeovascularization, PhysiologicStem CellsAnimalsEndothelium, VascularHumansIschemiaRegenerationStem Cell Transplantation

Identifiers

PMID20144623
PMCPMC2858691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.